Health Condition 1: M609- Myositis, unspecified
Conditions
Interventions
Intervention1: Occlusal Splint Therapy & Pharmacotherapy: Description: The intervention group will receive customized occlusal splint therapy and Pharmacotherapy. Participants will be prescribed NSA
Sponsors
Dr. Amol Karagir
Eligibility
Inclusion criteria
Inclusion criteria: Age Range: 20-30 years. Diagnosis: Myogenic temporomandibular disorders (TMD), specifically myofascial pain. Skeletal Growth Pattern: Average skeletal growth pattern (determined by composite cephalometric analysis). Consent: Written informed consent provided. No Prior TMJ Treatment: No previous temporomandibular joint or occlusal therapy.
Exclusion criteria
Exclusion criteria: Systemic Diseases: Conditions affecting TMJ or airway (e.g., rheumatoid arthritis, sleep apnea). Craniofacial Anomalies: Cleft palate, craniosynostosis, etc. Previous Orthodontic/Surgical Treatment: Orthodontic or craniofacial surgery. Pregnancy: Excluded due to hormonal influences and CBCT radiation. Respiratory Conditions: Asthma, COPD, chronic rhinitis, etc. Psychiatric Disorders: Conditions affecting compliance (e.g., schizophrenia, major depression). TMJ Degenerative Diseases: Osteoarthritis, ankylosis, etc. Malocclusion/Skeletal Discrepancies: Class II, Class III, severe open bite. Medication Use: Medications affecting muscle or TMJ function (e.g., corticosteroids). Non-compliance: Inability to adhere to the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Changes in Upper Airway Dimensions measured via CBCT Total Airway Volume: From nasopharynx to hypopharynx, measured in mm , Segmental Airway Volumes: Nasopharyngeal Volume in mm . Oropharyngeal Volume in mm . Hypopharyngeal Volume in mm Minimum Cross-Sectional Area : Smallest area within the airway, measured in mm Airway Length: Distance from the nasopharynx to the hypopharynx, measured in mm Presence of Obstructions or Anomalies: Identification of any airway obstructions (e.g., adenoids, hypertrophy). 2.Changes in Mandibular Condylar Position measured via CBCT Joint Space Measurements, Condylar Ratio, Angular and Morphological Parameters: Sagittal Condylar Guidance AngleTimepoint: Baseline: Before initiation of the intervention 3 Months: Final assessment using CBCT | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Comparison Between Groups: Differences in upper airway dimensions and mandibular condylar position across all groups: 2. Correlation Analysis: Relationship between changes in upper airway dimensions and alterations in mandibular condylar position. 3. Symptom Improvement: Patient-reported improvement in TMJD symptoms (e.g., pain reduction, increased jaw mobility). 4. Clinical Observations: Evaluation of the effectiveness of occlusal splint therapy in enhancing airway function and TMJ alignment. Timepoint: Baseline: Before initiation of the intervention 6 Weeks: Interim assessment for pain and functional improvement 3 Months: Final assessment using CBCT and patient-reported outcomes | — |
Countries
India
Contacts
Public ContactDr Amit Mhapuskar
Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Pune
Outcome results
None listed